Genocea Biosciences, Inc. (GNCA)

Trade GNCA now with
11/7/2017 8:14:52 AM Genocea Presents New Data Showing Power Of ATLAS Antigen Identification Platform At SITC 2017
11/2/2017 8:16:05 AM Genocea Q3 Net Loss $16.9 Mln Vs Loss $12.8 Mln Last Year
8/9/2017 8:05:24 AM Genocea Biosciences Q2 Net Loss $15.4 Mln Vs Loss Of $11.0 Mln Last Year
7/24/2017 7:03:59 AM Genocea Reports Positive Top-Line 12-Month Phase 2b Data For GEN-003 In Genital Herpes
5/4/2017 7:45:26 AM Genocea Q1 Net Loss $13.7 Mln Vs Loss Of $9.8 Mln Last Year
2/16/2017 7:34:45 AM Genocea Biosciences Q4 Net Loss Widens To $16.0 Mln From $10.3 Mln Last Year
1/5/2017 6:30:55 AM Genocea Announces Positive 6-Month Results From GEN-003 Phase 2b Clinical Trial
12/14/2016 7:33:06 AM Genocea Biosciences Announces Research Collaboration With Checkmate Pharmaceuticals
11/3/2016 7:53:05 AM Genocea Biosciences Q3 Net Loss $12.8 Mln Vs Net Loss $9.8 Mln Last Year
10/28/2016 7:41:34 AM Genocea Presents New 12 Month Immunogenicity Data From Phase 2a Trial Of Genital Herpes Immunotherapy GEN-003